| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| CAGR | 9.20% |
Major Players
*Disclaimer: Major Players sorted in no particular order |
South America Ovarian Cancer Diagnostics and Therapeutics Market Analysis by Mordor Intelligence
The South America Ovarian Cancer Diagnostics and Therapeutics Market is expected to register a CAGR of 9.2% during the forecast period.
The rising incidences of ovarian cancer are one of the primary drivers for the market. The cancer burden is increasing, owing to factors such as the aging population, poor diet, smoking, and physical inactivity. According to Globocan, in 2018, there were around 243,588 deaths due to cancer in Brazil. Ovarian cancer (OC) is the most common cancer among women. OC has a high mortality rate and is difficult to diagnose. Due to its silent progression, it is contributing to the high mortality rate. Thus, due to the increasing incidence of ovarian cancer, the market for cancer diagnostics and therapeutics is expected to see stable growth in South America. Additionally, the rising geriatric population and increase in healthcare expenditure also contribute to the growth of the market.
South America Ovarian Cancer Diagnostics and Therapeutics Market Trends and Insights
CT Scan Segment is Expected to Show Better Growth in the Forecast Years
- Based on Diagnosis, the market is segmented into Biopsy, Blood Tests, Ultrasound, PET, CT Scan and Other Diagnosis.
- Computed Tomography (CT) is an imaging procedure that uses special X-ray equipment to create detailed pictures, or scans, of areas inside the body. It is also called computerized tomography and computerized axial tomography (CAT). These equipment do not show small ovarian tumors well, but they can see larger tumors and may be able to see if the tumor is growing into nearby structures.
- The use of modern CT machines with robot-assisted surgical systems is improving surgical outcomes. Hence, CT machines are the highly beneficial and preferred method of imaging for many conditions, which is expected to propel the growth of the market, over the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
Competitive Landscape
The market for ovarian cancer diagnostics and therapeutics market in South America is moderately competitive and consists of the global players such as AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffman-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson and Siemens AG, Furthermore, with rising technological advancements and innovation, more companies are expected to penetrate the market in the coming future.
South America Ovarian Cancer Diagnostics and Therapeutics Industry Leaders
-
AstraZeneca plc
-
F. Hoffman-La Roche Ltd
-
GlaxoSmithKline plc
-
Johnson & Johnson
-
Siemens AG
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now
South America Ovarian Cancer Diagnostics and Therapeutics Market Report Scope
As per the scope of the report, Ovarian cancer is a type of cancer that begins in the ovaries. There are several types of ovarian cancer, among which Epithelial ovarian cancer is the most common type of ovarian cancer. The report covers various diagnostic and therapeutics used in the treatment of ovarian cancer.
By Cancer Type
| Epithelial Ovarian Tumors |
| Ovarian Germ Cell Tumors |
| Others |
By Modality
| Diagnosis | Biopsy |
| Blood Tests | |
| Ultrasound | |
| PET | |
| CT Scan | |
| Other Diagnosis | |
| Therapeutics | Chemotherapy |
| Radiation Therapy | |
| Immunotherapy | |
| Hormonal Therapy | |
| Others |
Geography
| South America | Brazil |
| Argentina | |
| Rest of South America |
| By Cancer Type | Epithelial Ovarian Tumors | |
| Ovarian Germ Cell Tumors | ||
| Others | ||
| By Modality | Diagnosis | Biopsy |
| Blood Tests | ||
| Ultrasound | ||
| PET | ||
| CT Scan | ||
| Other Diagnosis | ||
| Therapeutics | Chemotherapy | |
| Radiation Therapy | ||
| Immunotherapy | ||
| Hormonal Therapy | ||
| Others | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America | ||
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
What is the current South America Ovarian Cancer Diagnostics and Therapeutics Market size?
The South America Ovarian Cancer Diagnostics and Therapeutics Market is projected to register a CAGR of 9.2% during the forecast period (2025-2030)
Who are the key players in South America Ovarian Cancer Diagnostics and Therapeutics Market?
AstraZeneca plc, F. Hoffman-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson and Siemens AG are the major companies operating in the South America Ovarian Cancer Diagnostics and Therapeutics Market.
What years does this South America Ovarian Cancer Diagnostics and Therapeutics Market cover?
The report covers the South America Ovarian Cancer Diagnostics and Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the South America Ovarian Cancer Diagnostics and Therapeutics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
South America Ovarian Cancer Diagnostics and Therapeutics Market Report
Statistics for the 2025 South America Ovarian Cancer Diagnostics and Therapeutics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. South America Ovarian Cancer Diagnostics and Therapeutics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
